Live
IlluminaHow Singapore is solidifying its role at the forefront of global genomics - Illumina10x Genomics BlogCathie Wood’s ARK trims 10X Genomics stock, adds DraftKings By Investing.com - Investing.com South AfricaFierceBiotechAI could help spot heart disease in routine breast mammogram screeningsBioPharma DiveVertex kidney disease drug hits mark in late-stage studyThermo FisherThermo Fisher looks to shake up Bay Area biotech with 10-foot microscope - The Business JournalsIlluminaSPT-Illumina partnership ‘delivers core facilities to decentralised labs’ - Cambridge IndependentBioPharma DiveBristol Myers claims success in study of another next-gen blood cancer drugLonza NewsBRIEF—Lonza and Genetix Biotherapeutics extend deal - The Pharma LetterEndpoints NewsIpsen pulls cancer drug Tazverik from market over safety risksEndpoints NewsWhat Prasad's exit means for the FDA moving forwardAgilentAgilent Technologies to acquire Biocare Medical in $950m deal - Yahoo FinanceBioPharma DiveRoche’s prized breast cancer pill fails closely watched study
Roche Media Mar 6, 2026

Roche, Zealand tout the tolerability of their amylin obesity drug - TechTarget

Roche, Zealand tout the tolerability of their amylin obesity drug - TechTarget

Original
Body unavailable. Use the original source.

Directory

59 All